Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Sclerotherapy in venous malformation.

Rabe E, Pannier F.

Phlebology. 2013 Mar;28 Suppl 1:188-91. doi: 10.1177/0268355513477282. Review.

PMID:
23482557
2.

Outcomes and complications of sclerotherapy for venous malformations.

Qiu Y, Chen H, Lin X, Hu X, Jin Y, Ma G.

Vasc Endovascular Surg. 2013 Aug;47(6):454-61. doi: 10.1177/1538574413492390. Epub 2013 Jun 11. Review.

PMID:
23759722
3.

Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.

Li L, Feng J, Zeng XQ, Li YH.

J Vasc Surg. 2009 Apr;49(4):961-7. doi: 10.1016/j.jvs.2008.10.037.

4.

Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.

Blaise S, Charavin-Cocuzza M, Riom H, Brix M, Seinturier C, Diamand JM, Gachet G, Carpentier PH.

Eur J Vasc Endovasc Surg. 2011 Mar;41(3):412-7. doi: 10.1016/j.ejvs.2010.10.009. Epub 2010 Dec 15. Review.

5.

Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.

Ierardi AM, Mangini M, Vaghi M, Cazzulani A, Carrafiello G, Mattassi R.

Vasc Endovascular Surg. 2010 May;44(4):282-8. doi: 10.1177/1538574410362117.

PMID:
20403950
6.

Sclerotherapy: a study comparing polidocanol in foam and liquid form.

Uncu H.

Phlebology. 2010 Feb;25(1):44-9. doi: 10.1258/phleb.2009.008064.

PMID:
20118346
7.

Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.

Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T.

J Vasc Surg. 2008 Mar;47(3):578-84. doi: 10.1016/j.jvs.2007.11.026.

8.

Efficacy and evaluation of safety of sclerosants for intramuscular venous malformations: clinical and experimental studies.

Ozaki M, Kurita M, Kaji N, Fujino T, Narushima M, Takushima A, Harii K.

Scand J Plast Reconstr Surg Hand Surg. 2010 Apr;44(2):75-87. doi: 10.3109/02844310903569725.

PMID:
20465508
9.

Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations.

Ali H, Saleh M, Mohammed W.

Int Angiol. 2017 Jun;36(3):228-236. doi: 10.23736/S0392-9590.16.03732-9. Epub 2016 Jun 30.

PMID:
27362577
10.

Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.

Jin Y, Lin X, Li W, Hu X, Ma G, Wang W.

J Vasc Surg. 2008 Jun;47(6):1292-9. doi: 10.1016/j.jvs.2008.01.010. Epub 2008 Apr 3.

11.

Sclerotherapy complications of peripheral venous malformations.

Aronniemi J, Castrén E, Lappalainen K, Vuola P, Salminen P, Pitkäranta A, Pekkola J.

Phlebology. 2016 Dec;31(10):712-722. doi: 10.1177/0268355515613740. Epub 2016 Jul 9.

PMID:
26494223
12.

Digital subtraction angiography-guided foam sclerotherapy of peripheral venous malformations.

Li L, Zeng XQ, Li YH.

AJR Am J Roentgenol. 2010 May;194(5):W439-44. doi: 10.2214/AJR.09.3416.

PMID:
20410391
13.

Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.

Kishi K, Morita N, Terada T, Sato M.

Phlebology. 2014 Jun;29(5):276-86. doi: 10.1177/0268355513475604. Epub 2013 May 3.

PMID:
23508004
14.

European guidelines for sclerotherapy in chronic venous disorders.

Rabe E, Breu FX, Cavezzi A, Coleridge Smith P, Frullini A, Gillet JL, Guex JJ, Hamel-Desnos C, Kern P, Partsch B, Ramelet AA, Tessari L, Pannier F; Guideline Group.

Phlebology. 2014 Jul;29(6):338-54. doi: 10.1177/0268355513483280. Epub 2013 May 3.

PMID:
23559590
15.

A new method for using radiopaque sclerosing foam to treat venous malformations.

Li K, Liu YR, Chen AW, Liu SH.

Dermatol Surg. 2015 Jun;41(6):726-30. doi: 10.1097/DSS.0000000000000363.

PMID:
25973562
16.

Vascular malformations: an update.

Gloviczki P, Duncan A, Kalra M, Oderich G, Ricotta J, Bower T, McKusick M, Bjarnason H, Driscoll D.

Perspect Vasc Surg Endovasc Ther. 2009 Jun;21(2):133-48. doi: 10.1177/1531003509343019. Epub 2009 Aug 26. Review.

PMID:
19713211
17.

Indications, contraindications and performance: European Guidelines for Sclerotherapy in Chronic Venous Disorders.

Rabe E, Pannier F; for the Guideline Group.

Phlebology. 2014 May;29(1 suppl):26-33. Epub 2014 May 19. Review.

PMID:
24843082
18.

Percutaneous sclerotherapy for spongiform venous malformations - analysis of patient-evaluated outcome and satisfaction.

Clemens RK, Baumann F, Husmann M, Meier TO, Thalhammer C, MacCallum G, Amann-Vesti BR, Alomari AI.

Vasa. 2017 Oct;46(6):477-483. doi: 10.1024/0301-1526/a000650. Epub 2017 Aug 25.

PMID:
28841126
19.

Sclerotherapy for low-flow vascular malformations of the head and neck: A systematic review of sclerosing agents.

Horbach SE, Lokhorst MM, Saeed P, de Goüyon Matignon de Pontouraude CM, Rothová A, van der Horst CM.

J Plast Reconstr Aesthet Surg. 2016 Mar;69(3):295-304. doi: 10.1016/j.bjps.2015.10.045. Epub 2015 Nov 18. Review.

PMID:
26723834
20.

Sodium tetradecyl sulphate sclerotherapy for treating venous malformations of the oral and pharyngeal regions in children.

Stimpson P, Hewitt R, Barnacle A, Roebuck DJ, Hartley B.

Int J Pediatr Otorhinolaryngol. 2012 Apr;76(4):569-73. doi: 10.1016/j.ijporl.2012.01.019. Epub 2012 Feb 14.

PMID:
22341629

Supplemental Content

Support Center